New concepts in organ transplantation

Transplantation Proceedings

Volumn 36, Issue 5, 2004, Pages 1219-1224

  Haberal, M ^a   Dalgic, A ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

2 CYANO 3 HYDROXY N [4 (TRIFLUOROMETHYL)PHENYL] 6 HEPTYNAMIDE; AZATHIOPRINE; CALCINEURIN INHIBITOR; CD20 ANTIBODY; CD40 LIGAND MONOCLONAL ANTIBODY; CORTICOSTEROID; CYCLOSPORIN A; FINGOLIMOD; GABEXATE MESILATE; IMMUNOGLOBULIN; INTERLEUKIN 2 RECEPTOR ANTIBODY; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CH 52; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PROSTAGLANDIN E; RAPAMYCIN; TACROLIMUS; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ARTERY THROMBOSIS; BILIARY TRACT DISEASE; BLOOD GROUP ABO INCOMPATIBILITY; CELL TRANSPLANTATION; DIABETES MELLITUS; DRAIN; GRAFT SURVIVAL; HEART BEAT; HEPATIC ARTERY; HEPATIC VEIN; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; INTENSIVE CARE UNIT; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LAPAROSCOPIC SURGERY; LIVER TRANSPLANTATION; LOW DRUG DOSE; MALIGNANT NEOPLASTIC DISEASE; NEPHRECTOMY; ORGAN DONOR; ORGAN TRANSPLANTATION; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SURGICAL STAPLING; VEIN ANASTOMOSIS; XENOGRAFT;

EID: 3142604789     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.05.035     Document Type: Article

References (40)

1. McMaster P., Dousset B. The improved results of liver transplantation. Transplant Int. 5:1992;125
2. Adam R., McMaster P., O'Grady J.G., et al. Evolution of liver transplantation in Europe report of the European Liver Transplant Registry. Liver Transplant. 9:2003;1231
3. Busuttil R.W., Tanaka K. The utility of marginal donors in liver transplantation. Liver Transplant. 9:2003;651
4. Abouna G.M. Marginal donors a viable solution for organ shortage. Transplant Proc. 29:1997;2759
5. Cadaveric and living donor characteristics. Data Highlights. In: The Organ procurement and transplantation network, The US scientific registry of transplant recipients. Annual Report 1989-1998. HHS/HRSA/OPS/DOT; UNOS: 1-18, 1999
6. Abouna G.M., Al-Adnani M.S. Is diabetic nephropathy reversible? Transplant Proc. 19:(suppl 2):1987;82
7. Hiraga S. An overview of current non-heart-beating donor transplantation. Transplant Proc. 29:1997;3559
8. Hoffmann R.M., Knechtle S.J., et al. Successful extrarenal transplantation from non-heart-beating donors. Transplantation. 15:1995;59-977
9. D'Alessandro AM: Non-heart beating donors. The use of renal and non-renal organs. Plenary session III of the International Society for Organ Donation and Procurement 7th Congress, 031N, 2003
10. Shaheen F: Cadaveric and living organ donation. Natural limitations. Possible solutions. Plenary session II of the 7th Congress of the Middle East Experience International Society for Organ Donation and Procurement, 006N, 2003
11. Tanaka K. Progress and future in living donor liver transplantation. Keio J Med. 52:2003;73
12. Haberal M., Gulay H., Arslan G., et al. ABO-incompatible kidney transplantation with skin grafting. Transplant Proc. 21:1989;781
13. Haberal M., Gulay H., Tokyay R., et al. Living unrelated donor kidney transplantation between spouses. World J Surg. 16:1992;1183
14. Karakayali H., Moray G., Demirag A., et al. Long-term follow-up of ABO-incompatible renal transplant recipients. Transplant Proc. 31:1999;256
15. Akiawa A., Yamashita M., Hadano T., et al. ABO incompatible kidney transplantation - immunological aspect. Exp Clin Transplant. 2:2003;112
16. Tanaka K., Kiuchi T.J. Living-donor liver transplantation in the new decade perspective from the twentieth to the twenty-first century. Hepatobil Pancreat Surg. 9:2002;218
17. Kiuchi T., Kasahara M., Uryuhara K., et al. Impact of graft size mismatching on graft prognosis in liver transplantation from living donors. Transplantation. 27:1999;321
18. Haberal M., Tokyay R., Telatar H., et al. Living related and cadaver donor liver transplantation. Transplant Proc. 24:1992;1967
19. Haberal M., Telatar H., Demirag A., et al. Is needle biopsy mandatory for donor selection in live donor segmental liver transplantation? Transplant Proc. 27:1995;2605
20. Byun J.H., Kim T.K., Lee S.S., et al. Evaluation of the hepatic artery in potential donors for living donor liver transplantation by computed tomography angiography using multidetector-row computed tomography comparison of volume rendering and maximum intensity projection techniques. J Comput Assist Tomogr. 27:2003;125
21. Kanazawa A., Hirohashi K., Tanaka H., et al. Usefulness of three-dimensional computed tomography in a living-donor extended right lobe liver transplantation. Liver Transplant. 8:2002;1076
22. Moreno-Gonzalez E., Meneu-Diaz J.G., Fundora Y., et al. Advantages of the piggy back technique on intraoperative transfusion, fluid consumption, and vasoactive drugs requirements in liver transplantation a comparative study. Transplant Proc. 35:2003;1918
23. Lerut J.P., Molle G., Donataccio M., et al. Cavocaval liver transplantation without venovenous bypass and without temporary portocaval shunting the ideal technique for adult liver grafting? Transplant Int. 10:1997;171
24. Azoulay D., Marin-Hargreaves G., Castaing D., et al. Duct-to-duct biliary anastomosis in living related liver transplantation the Paul Brousse technique. Arch Surg. 136:2001;1197
25. Dalgic A., Dalgic B., Demirogullari B., et al. Clinical approach to graft hepatic artery thrombosis following living related liver transplantation. Pediatr Transplant. 7:2003;149
26. Hatano E., Terajima H., Yabe S., et al. Hepatic artery thrombosis in living related liver transplantation. Transplantation. 27:1997;64-1443
27. Boyvat F., Aytekin C., Firat A., et al. Diagnostic and therapeutic management of hepatic artery thrombosis and stenosis after orthotopic and heterotopic liver transplantation. Transplant Proc. 35:2003;2791
28. Simforoosh N., Bassiri A., Ziaee S.A., et al. Laparoscopic versus open live donor nephrectomy the first randomized clinical trial. Transplant Proc. 35:2003;2553
29. Jacobs S.C., Cho E., Foster C., et al. Laparoscopic donor nephrectomy the University of Maryland 6-year experience. J Urol. 171:2004;47
30. Hirose R., Vincenti F. Review of transplantation - 1999. Clin Transplant. 1999;295
31. Gourishankar S., Turner P., Halloran P. New developments in immunosuppressive therapy in renal transplantation. Expert Opin Biol Ther. 2:2002;483
32. Koshiba T., Van Damme B., Rutgeerts O., et al. FTY720, an immunosuppressant that alters lymphocyte trafficking, abrogates chronic rejection in combination with cyclosporine A. Transplantation. 15:2003;75-945
33. Vincenti F. What's in the pipeline? New immunosuppressive drugs in transplantation. Am J Transplant. 2:2002;898
34. Kahan BD, Lagner R, Troncoso P, et al. Selectin inhibitor bimosiamose (BIMO), ICAM-1 and FTY720 prevent reperfusion ischemic injury. Seventh Congress of the International Society for Organ Donation and Procurement, 075A:54, 2003
35. Ponticelli C: Avoiding corticosteroids in renal transplantation. A feasible strategy? ESOT mini updates in transplantation. European Society for Organ Transplantation. www.esot.org/news/miniupdates.html, 2003
36. McMaster P., Gunson B., Min X., et al. Liver transplantation changing goals in immunosuppression. Transplant Proc. 30:1998;1819
37. Padbury R.T., Toogood G.J., McMaster P. Withdrawal of immunosuppression in liver allograft recipients. Liver Transplant Surg. 4:1998;242
38. Heeger P.S. What's new and what's hot in transplantation. Basic science ATC 2003. Am J Transplant. 3:2003;1474
39. Starzl T.E., Rao A.S., Murase N., et al. Will xenotransplantation ever be feasible? J Am Coll Surg. 186:1998;383
40. Starzl T.E., Murase N., Abu-Elmagd K., et al. Tolerogenic immunosuppression for organ transplantation. Lancet. 3:2003;361-1502